Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Handa RK et al. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. 1991 Am. J. Physiol. pmid:1907104
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Rizzo A et al. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2. 1995 Am. J. Physiol. pmid:7771545
Olson NC et al. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 1993 Am. J. Physiol. pmid:8460710
Zimmerman BJ et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. 1994 Am. J. Physiol. pmid:8160832
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Gaboury J et al. Nitric oxide prevents leukocyte adherence: role of superoxide. 1993 Am. J. Physiol. pmid:8214120
Asako H et al. Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery. 1992 Am. J. Physiol. pmid:1362329
DeFily DV et al. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. 1996 Am. J. Physiol. pmid:8764261
Harris NR et al. Influence of arteriovenular pairing on PAF-induced capillary filtration. 1999 Am. J. Physiol. pmid:9887023
Yamazaki M et al. Modulation of leukotriene B4 and platelet-activating factor binding to neutrophils. 1991 Am. J. Physiol. pmid:1653524
Bosch RJ et al. Effects of parathyroid hormone-related protein on human mesangial cells in culture. 1999 Am. J. Physiol. pmid:10600786
Kubes P et al. Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. 1991 Am. J. Physiol. pmid:1647676
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Sasaki T et al. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland. 1989 Am. J. Physiol. pmid:2692465
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Brock TA and Gimbrone MA Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells. 1986 Am. J. Physiol. pmid:3717361
Findlay SR et al. Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. 1981 Am. J. Physiol. pmid:7282914
Halonen M et al. Anatomic basis for species differences in peripheral lung strip contraction to PAF. 1990 Am. J. Physiol. pmid:2382734
Neuwirth R et al. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. 1989 Am. J. Physiol. pmid:2705543
Wood JG et al. Gastric microvascular actions of platelet-activating factor: role of leukocytes. 1992 Am. J. Physiol. pmid:1550241
Zheng ZG et al. Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro. 1993 Am. J. Physiol. pmid:8430791
Kalra VK et al. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. 1996 Am. J. Physiol. pmid:8945922
Kelly KJ et al. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. 1996 Am. J. Physiol. pmid:8946001
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Esplugues JV and Whittle BJ Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. 1989 Am. J. Physiol. pmid:2919672
Ardaillou N et al. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. 1985 Am. J. Physiol. pmid:3918460
Zhou W et al. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. 1992 Am. J. Physiol. pmid:1443133
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Bienvenu K et al. Modulation of leukocyte migration in mesenteric interstitium. 1994 Am. J. Physiol. pmid:7943404
Church DJ et al. Calcium influx in platelet activating factor-induced atrial natriuretic peptide release in rat cardiomyocytes. 1994 Am. J. Physiol. pmid:8166260
Perico N et al. Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. 1991 Am. J. Physiol. pmid:1713421
Wang J and Dunn MJ Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. 1987 Am. J. Physiol. pmid:2827506
Kornecki E and Ehrlich YH Diminished responsiveness of human platelets to platelet-activating factor during pregnancy. 1990 Am. J. Physiol. pmid:2396687
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Rabe KF et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. 1994 Am. J. Physiol. pmid:7943259
Koyama S et al. Type II pneumocytes release chemoattractant activity for monocytes constitutively. 1997 Am. J. Physiol. pmid:9176245
Chang SW et al. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. 1989 Am. J. Physiol. pmid:2801951
Mózes T et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. 1989 Am. J. Physiol. pmid:2802004
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Hines KL et al. PAF increases hepatic vascular resistance and glycogenolysis in vivo. 1991 Am. J. Physiol. pmid:1848410
Stahl GL et al. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. 1997 Am. J. Physiol. pmid:9227410
Sobhani I et al. Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands. 1995 Am. J. Physiol. pmid:7611410
Marchetti J et al. The parietal sheet of Bowman's capsule of rat renal glomerulus: a target of endothelin and PAF. 1995 Am. J. Physiol. pmid:7611446
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Martins MA et al. Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. 1991 Am. J. Physiol. pmid:1722649
Johnson A et al. Tumor necrosis factor-alpha primes pulmonary hemodynamic response to N-formyl-L-methionyl-L-leucyl-L-phenylalanine. 1991 Am. J. Physiol. pmid:1656789